285 related articles for article (PubMed ID: 34617293)
1. Immune-mediated necrotizing myopathy: Unusual presentations of a treatable disease.
Nicolau S; Milone M; Tracy JA; Mills JR; Triplett JD; Liewluck T
Muscle Nerve; 2021 Dec; 64(6):734-739. PubMed ID: 34617293
[TBL] [Abstract][Full Text] [Related]
2. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
Merlonghi G; Antonini G; Garibaldi M
Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
[TBL] [Abstract][Full Text] [Related]
3. What Is in the Myopathy Literature?
Al-Lahham T; Lacomis D
J Clin Neuromuscul Dis; 2022 Sep; 24(1):38-48. PubMed ID: 36005472
[TBL] [Abstract][Full Text] [Related]
4. Immune-Mediated Necrotizing Myopathy.
Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
[TBL] [Abstract][Full Text] [Related]
5. [Acquired necrotizing myopathies].
Allenbach Y; Benveniste O
Rev Med Interne; 2013 Jun; 34(6):363-8. PubMed ID: 22998975
[TBL] [Abstract][Full Text] [Related]
6. Becker Muscular Dystrophy Accompanied by Anti-HMGCR Antibody-positive Immune-mediated Necrotizing Myopathy.
Munekane A; Ohsawa Y; Okubo M; Nagai T; Nishimura H; Nishino I; Sunada Y
Intern Med; 2023 May; 62(9):1345-1349. PubMed ID: 36130887
[TBL] [Abstract][Full Text] [Related]
7. Anti-signal recognition particle positive necrotizing myopathy-sjogren's syndrome overlap syndrome: a descriptive study on clinical and myopathology features.
Xu L; Yang MG; Hu L; Gao H; Ji S
BMC Musculoskelet Disord; 2023 Mar; 24(1):219. PubMed ID: 36959614
[TBL] [Abstract][Full Text] [Related]
8. The pathogenesis of anti-signal recognition particle necrotizing myopathy: A Review.
Qiu R; Wang Z; Wei X; Sui H; Jiang Z; Yu XF
Biomed Pharmacother; 2022 Dec; 156():113936. PubMed ID: 36411623
[TBL] [Abstract][Full Text] [Related]
9. Peculiar clinicopathological features of immune-mediated necrotizing myopathies.
Allenbach Y; Benveniste O
Curr Opin Rheumatol; 2018 Nov; 30(6):655-663. PubMed ID: 30239349
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.
Yang H; Tian X; Zhang L; Li W; Liu Q; Jiang W; Peng Q; Wang G; Lu X
BMC Musculoskelet Disord; 2022 May; 23(1):425. PubMed ID: 35524238
[TBL] [Abstract][Full Text] [Related]
11. Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
Allenbach Y; Benveniste O; Stenzel W; Boyer O
Nat Rev Rheumatol; 2020 Dec; 16(12):689-701. PubMed ID: 33093664
[TBL] [Abstract][Full Text] [Related]
12. Slowly Progressive Limb-Girdle Weakness and HyperCKemia - Limb Girdle Muscular Dystrophy or Anti-3-Hydroxy-3-Methylglutaryl-CoA-Reductase-Myopathy?
Hiebeler M; Franke R; Ingenerf M; Krause S; Mohassel P; Pak K; Mammen A; Schoser B; Bönnemann CG; Walter MC
J Neuromuscul Dis; 2022; 9(5):607-614. PubMed ID: 35754285
[TBL] [Abstract][Full Text] [Related]
13. Clinical associations of patients with anti-3-hydroxy-3-methylglutaryl CoA reductase antibody-associated immune-mediated necrotising myopathy.
Tan E; Knight J; Khonasti S; Nolan D; McGettigan B; Bundell C; Needham M; Brusch A
Intern Med J; 2023 Oct; 53(10):1846-1853. PubMed ID: 36625419
[TBL] [Abstract][Full Text] [Related]
14. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
[TBL] [Abstract][Full Text] [Related]
15. Dengue infection triggered immune mediated necrotizing myopathy in children: a case report and literature review.
Mekmangkonthong A; Amornvit J; Numkarunarunrote N; Veeravigrom M; Khaosut P
Pediatr Rheumatol Online J; 2022 Jun; 20(1):40. PubMed ID: 35672822
[TBL] [Abstract][Full Text] [Related]
16. Differential diagnosis of necrotizing myopathy.
Selva-O'Callaghan A; Trallero-Araguás E; Milisenda JC; Grau-Junyent JM
Curr Opin Rheumatol; 2021 Nov; 33(6):544-553. PubMed ID: 34482348
[TBL] [Abstract][Full Text] [Related]
17. Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy.
Anquetil C; Boyer O; Wesner N; Benveniste O; Allenbach Y
Autoimmun Rev; 2019 Mar; 18(3):223-230. PubMed ID: 30639649
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological Features of Myositis and Necrotizing Myopathy: How to Distinguish between Myositis and Muscular Dystrophy on Muscle Pathology].
Saito Y; Nishino I
Brain Nerve; 2021 Feb; 73(2):147-159. PubMed ID: 33561829
[TBL] [Abstract][Full Text] [Related]
19. Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy.
Lia A; Annese T; Fornaro M; Giannini M; D'Abbicco D; Errede M; Lorusso L; Amati A; Tampoia M; Trojano M; Virgintino D; Ribatti D; Serlenga L; Iannone F; Girolamo F
Rheumatology (Oxford); 2022 Aug; 61(8):3448-3460. PubMed ID: 34864921
[TBL] [Abstract][Full Text] [Related]
20. Immune-Mediated Necrotizing Myopathies: Current Landscape.
Koumas C; Michelassi F
Curr Neurol Neurosci Rep; 2024 May; 24(5):141-150. PubMed ID: 38589696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
